Delivery Order SPE2DB24D3013-SPE2DB25FFPPK
Award Date 8/19/25
Potential Completion Date 9/10/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for TABRECTA 200 mg tablets (56-count units) valued at $7,214.03 under a firm fixed-price contract type. The award, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $26,189.68 firm fixed price delivery order contract to provide TABRECTA 200 MG TABLET UU 56S pharmaceuticals. The contract has a completion date of March 25, 2024 and was awarded on March 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,428.06 firm-fixed-price delivery order is for TABRECTA 200 MG Tablets. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $14,428.06 on September 15, 2025, for the supply of Tabrecta 200 mg tablets (56-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a $14,428.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Tabrecta 200 mg tablets (56-count units). This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office location. The delivery order represents a typical...
- The Defense Logistics Agency awarded a $14.4K delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Tabrecta 200 mg tablets (56-count units). This non-set-aside, firm fixed-price contract is scheduled for completion by October 3, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product TABRECTA 200 MG TABLET. The award has a potential value of $6,547.42 and a completion date of March 21, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. The contract is not set aside for any specific...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,547.42 firm fixed-price delivery order is for the supply of TABRECTA 200 MG TABLET (National Drug Code 4566554061) with no set-aside designation, indicating open competition. The contract has an ultimate completion date of December 18, 2024 and was awarded on November 26, 2024. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,321.13 firm fixed-price delivery order contract is for the supply of TABRECTA 200 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of January 15, 2025 and was awarded on December 23, 2024. No set-aside designation was used for this open competition award. AmerisourceBergen...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,214.03 contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a performance period through June 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...